Why carry out this study?

Scoring balloon angioplasty (SBA) for acute lumen gain is an interventional tool for lesion preparation

Non-slip element scoring balloon catheter may be associated with enhanced lesion crossability

Drug-coated balloon (DCB) angioplasty was recently studied in small vessel de novo artery disease in the BASKET-SMALL II trial

What was learned from the study?

The combination of non-slip element scoring balloon catheter and DCB was safe and effective in the treatment of de novo coronary artery disease with target lesion failure rates of less than 2% at 9 months

There are no de novo subgroups, e.g., calcified lesions, larger vessels (≥ 3mm) which do not benefit from SBA/DCB treatment